Meridian Bioscience (LTS:0K0K) Additional Paid-In Capital : $155.7 Mil(As of Sep. 2022)

View and export this data going back to 2018. Start your Free Trial

What is Meridian Bioscience Additional Paid-In Capital?

Meridian Bioscience's quarterly additional paid-in capital increased from Mar. 2022 ($151.0 Mil) to Jun. 2022 ($154.2 Mil) and increased from Jun. 2022 ($154.2 Mil) to Sep. 2022 ($155.7 Mil).

Meridian Bioscience's annual additional paid-in capital increased from Sep. 2020 ($140.2 Mil) to Sep. 2021 ($147.4 Mil) and increased from Sep. 2021 ($147.4 Mil) to Sep. 2022 ($155.7 Mil).

Meridian Bioscience Additional Paid-In Capital Historical Data

The historical data trend for Meridian Bioscience's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Meridian Bioscience Additional Paid-In Capital Chart

Meridian Bioscience Annual Data

Trend

Sep13

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Additional Paid-In Capital

Get a 7-Day Free Trial

129.19

132.83

140.20

147.40

155.66

Meridian Bioscience Quarterly Data
	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Additional Paid-In Capital	Get a 7-Day Free Trial															147.40	148.62	150.99	154.24	155.66

Meridian Bioscience Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Meridian Bioscience Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Meridian Bioscience's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Meridian Bioscience (LTS:0K0K) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Meridian Bioscience Inc (LTS:0K0K) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

3471 River Hills Drive, Cincinnati, OH, USA, 45244

Website

https://www.meridianbioscience.com

Meridian Bioscience Inc is an integrated life science company. It develops and distributes diagnostic tests and reagents, as well as biologic substances used by pharmaceutical and biotechnology companies. Its Diagnostics segment manufactures tests primarily for gastrointestinal, viral, respiratory, & parasitic infectious diseases. Its testing platforms include isothermal DNA amplification, rapid immunoassays, and enzyme-linked immunoassays. The Life sciences segment sells b-antigens, antibodies, and reagents in bulk to other diagnostic manufacturers, the agriculture industry, and researchers. It also manufactures proteins that biopharmaceutical companies use in new drugs and vaccines. The entity has a business presence in the US and other countries.

Meridian Bioscience (LTS:0K0K) Headlines

No Headlines